Upadacitinib 30 mg Tops Atopic Dermatitis Systemic Therapies in Meta-Analyses
Updated analysis of more than a dozen clinical trials assessing monotherapy systemic treatment of atopic dermatitis shows upadacitinib's highly prevalent efficacy in clearing skin.